These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31651245)

  • 1. Impact of care coordination on oral anticoagulant therapy among patients with atrial fibrillation in routine clinical practice in Japan: a prospective, observational study.
    Ono F; Akiyama S; Suzuki A; Ikeda Y; Takahashi A; Matsuoka H; Sasaki M; Okamura T; Yoshihara N;
    BMC Cardiovasc Disord; 2019 Oct; 19(1):235. PubMed ID: 31651245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study.
    Ermini G; Perrone V; Veronesi C; Degli Esposti L; Di Pasquale G
    Vasc Health Risk Manag; 2017; 13():239-246. PubMed ID: 28740396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice.
    Wolff A; Shantsila E; Lip GY; Lane DA
    Age Ageing; 2015 Sep; 44(5):874-8. PubMed ID: 26082176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
    Olivier CB; Fan J; Askari M; Mahaffey KW; Heidenreich PA; Perino AC; Leef GC; Ho PM; Harrington RA; Turakhia MP
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e007604. PubMed ID: 31416357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection rate and treatment gap for atrial fibrillation identified through screening in community health centers in China (AF-CATCH): A prospective multicenter study.
    Chen Y; Huang QF; Sheng CS; Zhang W; Shao S; Wang D; Cheng YB; Wang Y; Guo QH; Zhang DY; Li Y; Lowres N; Freedman B; Wang JG
    PLoS Med; 2020 Jul; 17(7):e1003146. PubMed ID: 32673305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry.
    Boriani G; Proietti M; Laroche C; Diemberger I; Popescu MI; Riahi S; Shantsila A; Dan GA; Tavazzi L; Maggioni AP; Lip GYH;
    Int J Cardiol; 2018 Nov; 271():68-74. PubMed ID: 30001945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
    Martinez C; Katholing A; Wallenhorst C; Freedman SB
    Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study.
    Tulner LR; Van Campen JP; Kuper IM; Gijsen GJ; Koks CH; Mac Gillavry MR; van Tinteren H; Beijnen JH; Brandjes DP
    Drugs Aging; 2010 Jan; 27(1):39-50. PubMed ID: 20030431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective 5-year follow-up after population-based systematic screening for atrial fibrillation.
    Engdahl J; Holmén A; Rosenqvist M; Strömberg U
    Europace; 2018 Nov; 20(FI_3):f306-f311. PubMed ID: 29688312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of opportunistic atrial fibrillation screening for elderly patients in routine primary care.
    Suzuki A; Okamura T; Sasaki M; Matsuoka H; Ikeda Y; Takahashi A; Akiyama S; Ono F; Yoshihara N;
    PLoS One; 2020; 15(12):e0244240. PubMed ID: 33378380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
    Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.
    Wertheimer G; Bereznicki LR
    J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):46-53. PubMed ID: 29962220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake in antithrombotic treatment and its association with stroke incidence in atrial fibrillation: insights from a large German claims database.
    Hohnloser SH; Basic E; Nabauer M
    Clin Res Cardiol; 2019 Sep; 108(9):1042-1052. PubMed ID: 30771066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.
    Xanthopoulou I; Dragona VM; Davlouros P; Tsioufis C; Iliodromitis E; Alexopoulos D;
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):191-196. PubMed ID: 29679301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. eHealth Tools to Provide Structured Assistance for Atrial Fibrillation Screening, Management, and Guideline-Recommended Therapy in Metropolitan General Practice: The AF - SMART Study.
    Orchard J; Neubeck L; Freedman B; Li J; Webster R; Zwar N; Gallagher R; Ferguson C; Lowres N
    J Am Heart Assoc; 2019 Jan; 8(1):e010959. PubMed ID: 30590964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation　- The Fushimi AF Registry.
    Masunaga N; Abe M; Ogawa H; Aono Y; Ikeda S; Doi K; An Y; Ishii M; Iguchi M; Esato M; Tsuji H; Wada H; Hasegawa K; Lip GYH; Akao M;
    Circ J; 2018 Nov; 82(12):2983-2991. PubMed ID: 30381701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy for stroke prevention in patients with atrial fibrillation in Japan.
    Maruhashi T; Higashi Y
    Expert Opin Pharmacother; 2020 Dec; 21(17):2115-2124. PubMed ID: 32749891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.